DDIS-25. PENTAMIDINE; A NEW CHEMOTHERAPY TARGETING ON GLIOMA STEM LIKE CELLS

INTRODUCTION: Glioblastoma (GBM) is the most common primary malignant brain tumors. Despite aggressive therapies, median overall survival of patients who suffered from GBM is only 18 months. Furthermore, there is no effective therapy for glioma stem cells (GSCs), which act as forming tumors. Herein,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Tamai, Sho, Jiapaer, Shabierjiang, Zhang, Guangtao, Zhang, Jiakang, Wang, Yi, Sabit, Hemragul, Tanaka, Shingo, Kinoshita, Masashi, Hirao, Atsushi, Nakada, Mitsutoshi
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Drug Discovery
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847863/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.276
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars